NSEAnalysts/Institutional Investor Meet/Con. Call Updates21 Oct 2026 · 21 Oct 2026, 12:07 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Sudeep Pharma Limited · SUDEEPPHRM
✦ AI SummaryResults
Sudeep Pharma Limited has scheduled an earnings call with analysts and investors on October 29, 2026, to discuss its Q2 and H1FY27 results.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sudeep Pharma Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
SUDEEPPHARMALIMITED_21102026120643_Intimation_for_Earnings_Call.pdf
View document text
Date: 21st October 2026
National Stock Exchange of India Limited BSE Limited Phiroze Jeejeebhoy Towers
Exchange Plaza, C-1, Block G Bandra Kurla Dalal Street, Mumbai – 400001
Complex, Bandra (E), Mumbai – 400051 Scrip Code: 544619
Scrip Symbol- SUDEEPPHRM
Sub: Intimation of Earnings Call with Analysts/Investors on 29th October 2026
Ref: Regulation 30 of the SEBI Listing Regulations, 2015
Dear Sir/Ma’am,
This is to inform that the “Earnings Call” of the Company with Analysts/Investors to discuss
the operational & financial performance for the quarter and half year ended on 30th September
2026, is scheduled as below:
Day & Date: Thursday, 29th October 2026
Time: 12:00 noon.
Registration Link and Access numbers: As per Annexure
Copy of Earnings Call invite is annexed herewith and is also hosted on our website
https://www.sudeeppharma.com/investor-relations/financial-results/#concall-invitation
Kindly take the same on record.
Thanking You.
For Sudeep Pharma Limited
Dimple Mehta
Company Secretary & Compliance Officer
M. No.: F13184
ENCL: A/a
CIN: L24231GJ1989PLC013141
Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India.
Phone No.: +91 265 2840656, 7624095107
Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat,
India Website: www.sudeeppharma.com, Email ID: mail@sudeepgroup.com
CONCALL INVITE
360 ONE CM Research shall hold
a Conference Call of
Sudeep Pharma Limited
to discuss the Q2 & H1FY27 Results
on Thursday, 29th October 2026 at 12:00 Hrs IST
The Management Team will be represented by:
Mr. Sujit Bhayani – Managing Director
Mr. Shanil Bhayani – Director
Mr. Ketan Vyas – Chief Financial Officer
You are cordially invited
Diamond Pass Link
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0914184&linkSecuritySt
ring=80396a198
Universal Dial-in Numbers
+91 22 6280 1222 / +91 22 7115 8123
International Toll Free:
Argentina: 0080014243444 | Australia: 0080014243444 | Belgium: 0080014243444 | Canada: 01180014243444
China: 4008428405 | France: 0800914745 | Germany: 0080014243444 | Hong Kong: 800964448
Italy: 0080014243444 | Japan: 00531161110 | Netherlands: 08000229808 | Poland: 008001124248
Singapore: 8001012045 | South Korea: 00180014243444 | Sweden: 0080014243444
Thailand: 00180014243444 | UK: 08081011573 | USA: 18667462133
For further information, please contact
Mr. Rohit Nagraj
360 ONE Capital Market Research
+91-22-4031 7127
rohit.nagraj@360.one